Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of a Bi-annual Community-directed Treatment With Ivermectin Programme on the Incidence of Epilepsy in an Onchocerciasis-endemic Area of Mahenge, Tanzania: a Population-based Prospective Study

NCT05749653 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT05749653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05749653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of a Bi-annual Community-directed Treatment With Ivermectin Programme on the Incidence of Epilepsy in an Onchocerciasis-endemic Area of Mahenge, Tanzania: a Population-based Prospective Study
Lead sponsor
Universiteit Antwerpen
Phase
Not applicable
Overall status
Completed
Start date
March 1, 2017
Completion date
February 1, 2022
Enrollment
6,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, onchocerciasis